Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zentalis Pharmaceuticals, LLC

1.36
+0.07005.43%
Volume:799.84K
Turnover:1.10M
Market Cap:97.66M
PE:-0.58
High:1.41
Open:1.29
Low:1.28
Close:1.29
Loading ...

BRIEF-Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
02 Apr

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
02 Apr

Promising Potential and Strategic Positioning Justify Buy Rating for Zentalis Pharmaceuticals

TIPRANKS
·
01 Apr

Analysts Conflicted on These Healthcare Names: Zentalis Pharmaceuticals (ZNTL) and Viking Therapeutics (VKTX)

TIPRANKS
·
31 Mar

Guggenheim Sticks to Their Buy Rating for Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
30 Mar

Zentalis Pharmaceuticals Price Target Maintained With a $4.00/Share by Wedbush

Dow Jones
·
28 Mar

Stifel Nicolaus Sticks to Their Buy Rating for Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
27 Mar

Oppenheimer Remains a Buy on Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
27 Mar

Zentalis Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Mar

BRIEF-Zentalis Pharmaceuticals Inc Files For Mixed Shelf Of Up To $250 Million - SEC Filing

Reuters
·
27 Mar

Zentalis Pharmaceuticals Inc Files for Mixed Shelf of up to $250 Mln - SEC Filing

THOMSON REUTERS
·
27 Mar

Zentalis Pharmaceuticals FY24 EPS ($2.33) Up From ($4.47) YoY)

Benzinga
·
27 Mar

Press Release: Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates

Dow Jones
·
27 Mar

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
21 Mar

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
17 Mar

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer

GlobeNewswire
·
15 Mar

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
10 Mar

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
05 Mar

BRIEF-Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
04 Mar

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
04 Mar